IN2015DN02782A - - Google Patents
Info
- Publication number
- IN2015DN02782A IN2015DN02782A IN2782DEN2015A IN2015DN02782A IN 2015DN02782 A IN2015DN02782 A IN 2015DN02782A IN 2782DEN2015 A IN2782DEN2015 A IN 2782DEN2015A IN 2015DN02782 A IN2015DN02782 A IN 2015DN02782A
- Authority
- IN
- India
- Prior art keywords
- composition
- cancer
- risk
- nicotine
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/008—Electronic counters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/0083—Timers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F13/00—Appliances for smoking cigars or cigarettes
- A24F13/02—Cigar or cigarette holders
- A24F13/12—Cigar or cigarette holders combined with other objects, e.g. writing utensils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0085—Inhalators using ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Physiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Addiction (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261703999P | 2012-09-21 | 2012-09-21 | |
| US14/013,019 US20140088045A1 (en) | 2012-09-21 | 2013-08-28 | Product comprising a nicotine-containing material and an anti-cancer agent |
| PCT/US2013/061206 WO2014047569A2 (fr) | 2012-09-21 | 2013-09-23 | Produit comprenant une matière contenant de la nicotine et un agent anticancéreux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN02782A true IN2015DN02782A (fr) | 2015-09-04 |
Family
ID=50339457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2782DEN2015 IN2015DN02782A (fr) | 2012-09-21 | 2013-09-23 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20140088044A1 (fr) |
| EP (1) | EP2916847A4 (fr) |
| JP (1) | JP2015531793A (fr) |
| KR (1) | KR20150084794A (fr) |
| CN (1) | CN104918621A (fr) |
| CA (1) | CA2885739A1 (fr) |
| EA (1) | EA201590585A1 (fr) |
| IN (1) | IN2015DN02782A (fr) |
| WO (1) | WO2014047569A2 (fr) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011133867A2 (fr) * | 2010-04-23 | 2011-10-27 | The Regents Of The University Of Colorado, A Body Corporate | Vaccins, procédés d'administration de vaccins, méthodes et produits pour traiter et/ou retarder l'apparition de lésions dysplasiques, et gaufrettes à usage oral |
| EP2654864B1 (fr) | 2010-12-22 | 2020-10-28 | Syqe Medical Ltd. | Système d'administration de médicament |
| FR3015186A1 (fr) * | 2014-03-11 | 2015-06-26 | Antoine Piccirilli | Utilisation d'une composition renfermant du 1,3-propanediol comme e-liquide |
| WO2015148649A2 (fr) * | 2014-03-26 | 2015-10-01 | Basil Rigas | Systèmes et procédés d'amélioration des effets de produits du tabac |
| JP6672258B2 (ja) * | 2014-04-08 | 2020-03-25 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | ニコチン製剤及びその作製方法 |
| RU2680422C2 (ru) | 2014-04-28 | 2019-02-21 | Филип Моррис Продактс С.А. | Ингалятор ароматизированного никотинового порошка |
| UA122894C2 (uk) | 2014-04-28 | 2021-01-20 | Філіп Морріс Продактс С.А. | Інгалятор нікотинового порошку |
| ES2743898T3 (es) | 2014-04-28 | 2020-02-21 | Philip Morris Products Sa | Inhalador de polvo nicotina |
| EP3148982A1 (fr) * | 2014-05-27 | 2017-04-05 | R. J. Reynolds Tobacco Company | Sels, co-cristaux, et complexes de co-cristaux de sels de nicotine |
| US9896429B2 (en) | 2014-05-27 | 2018-02-20 | R.J. Reynolds Tobacco Company | Nicotine salts, co-crystals, and salt co-crystal complexes |
| US10508096B2 (en) | 2014-05-27 | 2019-12-17 | R.J. Reynolds Tobacco Company | Nicotine salts, co-crystals, and salt co-crystal complexes |
| GB2527597B (en) * | 2014-06-27 | 2016-11-23 | Relco Induction Dev Ltd | Electronic Vapour Inhalers |
| MX378843B (es) | 2014-06-30 | 2025-03-10 | Syqe Medical Ltd | Cartucho de dosis de farmaco para un dispositivo inhalador. |
| MX2017000057A (es) | 2014-06-30 | 2017-06-30 | Syqe Medical Ltd | Procedimiento y dispositivo para vaporizacion e inhalacion de sustancias aisladas. |
| US11298477B2 (en) | 2014-06-30 | 2022-04-12 | Syqe Medical Ltd. | Methods, devices and systems for pulmonary delivery of active agents |
| CN106604755B (zh) | 2014-06-30 | 2020-08-11 | Syqe医药有限公司 | 流量调节的吸入器装置 |
| EP3160565B1 (fr) | 2014-06-30 | 2021-08-18 | Syqe Medical Ltd. | Dispositifs et systèmes pour administration pulmonaire d'agents actifs |
| WO2016001922A1 (fr) * | 2014-06-30 | 2016-01-07 | Syqe Medical Ltd. | Procédés, dispositifs et systèmes utilisables en vue de l'administration pulmonaire d'agents actifs |
| EA201790930A1 (ru) | 2014-10-29 | 2017-08-31 | Олтриа Клайент Сервисиз Ллк | Картридж электронного вейпингового устройства |
| US10772352B2 (en) | 2014-10-29 | 2020-09-15 | Altria Client Services Llc | Ethanol-free gel formulation cartridge for e-vaping device |
| US11338099B2 (en) | 2014-12-24 | 2022-05-24 | Philip Morris Products S.A. | Nicotine powder delivery system |
| CN104544542B (zh) * | 2014-12-24 | 2017-04-26 | 广西中烟工业有限责任公司 | 一种真空冷冻干燥薄荷粒电子烟油的制备方法 |
| GB2534210B (en) * | 2015-01-19 | 2017-07-19 | Ngip Res Ltd | Aerosol-generating article |
| KR102641134B1 (ko) * | 2015-04-15 | 2024-02-28 | 필립모리스 프로덕츠 에스.에이. | 흡입 디바이스를 위한 향료 요소 |
| US9585835B1 (en) * | 2015-09-16 | 2017-03-07 | Sansa Corporation (Barbados) Inc. | Inhalable nicotine formulations and methods of making and using the same |
| US10149844B2 (en) | 2015-09-16 | 2018-12-11 | Philip Morris Products S.A. | Inhalable nicotine formulations, and methods of making and using thereof |
| CN108495563B (zh) * | 2015-11-25 | 2022-04-26 | R.J.雷诺兹烟草公司 | 烟碱盐、共晶体和盐共晶体配合物 |
| WO2017109678A1 (fr) | 2015-12-24 | 2017-06-29 | Philip Morris Products S.A. | Capsule de particule de nicotine |
| MY186270A (en) | 2015-12-24 | 2021-07-01 | Philip Morris Products Sa | Flavoured nicotine powder |
| ES2874087T3 (es) | 2016-01-06 | 2021-11-04 | Syqe Medical Ltd | Tratamiento terapéutico con dosis bajas |
| US9867397B2 (en) | 2016-01-11 | 2018-01-16 | Patrick Beymer | Nicotine delivery system |
| GB201602831D0 (en) | 2016-02-18 | 2016-04-06 | British American Tobacco Co | Flavour delivery device |
| CN109328083B (zh) | 2016-07-07 | 2021-07-02 | 菲利普莫里斯生产公司 | 尼古丁吸入器系统 |
| US20180036496A1 (en) * | 2016-08-02 | 2018-02-08 | James Riviello | Medication Delivery System |
| BR112021009438A2 (pt) * | 2018-12-28 | 2021-08-17 | Philip Morris Products S.A. | formulação de nicotina compreendendo sal metálico |
| US20220087305A1 (en) * | 2018-12-28 | 2022-03-24 | Philip Morris Products S.A. | High viscosity nicotine formulation |
| BR112021010229A2 (pt) * | 2018-12-28 | 2021-08-24 | Philip Morris Products S.A. | Formulação de nicotina líquida compreendendo sal de metal de baixa massa molar |
| JP7171910B2 (ja) * | 2019-05-21 | 2022-11-15 | 日本たばこ産業株式会社 | 加熱型香味吸引器用香料含有シートおよび加熱型香味吸引器 |
| WO2021126313A1 (fr) * | 2019-07-15 | 2021-06-24 | The Research Foundation For The State University Of New York | Matériaux de nicotine, leurs procédés de fabrication et leurs utilisations |
| LU101519B1 (en) * | 2019-12-02 | 2021-06-07 | Herrera Arturo Solis | (S)-3-[1-MethyIpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a solid substance and a tablet |
| WO2022102544A1 (fr) * | 2020-11-13 | 2022-05-19 | 日本たばこ産業株式会社 | Extrait de tabac contenant du cémbratrienediol et son procédé de production |
| US12036286B2 (en) | 2021-03-18 | 2024-07-16 | Seagen Inc. | Selective drug release from internalized conjugates of biologically active compounds |
| EP4609854A1 (fr) * | 2022-10-27 | 2025-09-03 | KT&G Corporation | Composition à inhaler de poudre sèche de nicotine à faible dose |
| WO2024194922A1 (fr) * | 2023-03-17 | 2024-09-26 | 日本たばこ産業株式会社 | Composition d'arôme et inhalateur d'arôme |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050236006A1 (en) * | 2004-04-24 | 2005-10-27 | Anderson Cowan | Smoking cessation devices, methods of use and methods of conducting business therewith |
| PL2180788T3 (pl) * | 2007-08-10 | 2017-06-30 | Basil Rigas | Związki przeciwzapalne i ich zastosowanie |
| US20100124560A1 (en) * | 2008-11-14 | 2010-05-20 | Mcneil Ab | Multi portion intra-oral dosage form and use thereof |
| WO2011133475A2 (fr) * | 2010-04-19 | 2011-10-27 | Sri International | Compositions et méthode utilisées pour le traitement du myélome multiple |
| WO2011133215A1 (fr) * | 2010-04-19 | 2011-10-27 | Health Research Inc. | Procédé d'identification et de traitement d'un individu présentant une prédisposition à la maladie de parkinson ou étant atteint de cette maladie. |
-
2013
- 2013-08-28 US US14/013,004 patent/US20140088044A1/en not_active Abandoned
- 2013-08-28 US US14/013,019 patent/US20140088045A1/en not_active Abandoned
- 2013-09-23 CN CN201380060815.2A patent/CN104918621A/zh active Pending
- 2013-09-23 EP EP13882621.9A patent/EP2916847A4/fr not_active Withdrawn
- 2013-09-23 JP JP2015533249A patent/JP2015531793A/ja active Pending
- 2013-09-23 IN IN2782DEN2015 patent/IN2015DN02782A/en unknown
- 2013-09-23 KR KR1020157010149A patent/KR20150084794A/ko not_active Withdrawn
- 2013-09-23 CA CA2885739A patent/CA2885739A1/fr not_active Abandoned
- 2013-09-23 EA EA201590585A patent/EA201590585A1/ru unknown
- 2013-09-23 WO PCT/US2013/061206 patent/WO2014047569A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014047569A3 (fr) | 2014-07-17 |
| EP2916847A2 (fr) | 2015-09-16 |
| CN104918621A (zh) | 2015-09-16 |
| US20140088045A1 (en) | 2014-03-27 |
| EA201590585A1 (ru) | 2016-04-29 |
| WO2014047569A2 (fr) | 2014-03-27 |
| US20140088044A1 (en) | 2014-03-27 |
| CA2885739A1 (fr) | 2014-03-27 |
| KR20150084794A (ko) | 2015-07-22 |
| JP2015531793A (ja) | 2015-11-05 |
| EP2916847A4 (fr) | 2016-06-08 |
| WO2014047569A9 (fr) | 2014-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN02782A (fr) | ||
| WO2015148649A3 (fr) | Systèmes et procédés d'amélioration des effets de produits du tabac | |
| PH12012500540A1 (en) | Improved device and method for delivery of a medicament | |
| MX2009009428A (es) | Analogos de ciclopamina heterociclicos y metodos de uso de los mismos. | |
| MX2020010535A (es) | Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide. | |
| SG178873A1 (en) | Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors | |
| MX2009009429A (es) | Analogos de ciclopamina lactama y metodos de uso de los mismos. | |
| MD20150035A2 (ro) | Inhibitori de tirozinkinaza Bruton | |
| PH12016500575A1 (en) | Inhibitors of bruton`s tyrosine kinase | |
| SG10201811128RA (en) | Ezh2 inhibitors for treating lymphoma | |
| MX2016007826A (es) | Compuestos peptidomimeticos y sus conjugados de anticuerpo-farmaco. | |
| PH12015501067A1 (en) | Pyrrolopyrimidine compounds as kinase inhibitors | |
| NZ748451A (en) | Methods for treating atopic dermatitis by administering an il-4r antagonist | |
| PH12014501815A1 (en) | Purinone compounds as kinase inhibitors | |
| PH12012502399A1 (en) | Combination therapy methods for treating proliferative diseases | |
| IN2014DN10889A (fr) | ||
| MX2011011126A (es) | Composiciones y metodos para tratar quemaduras. | |
| MY181602A (en) | Isochromene derivatives as phosphoinositide 3-kinases inhibitors | |
| PH12015500062A1 (en) | 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments | |
| WO2012005885A3 (fr) | Produit nutraceutique contenant de l'anatabine et du maté | |
| IN2015DN03854A (fr) | ||
| NZ711564A (en) | Methods of treating colorectal cancer | |
| MY171526A (en) | Pharmaceutical formulation for reducing frequency of urination and method of use thereof | |
| IN2014DN09437A (fr) | ||
| PH12017500505A1 (en) | Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers |